Clinical trials
Pancreatic Neoplasms trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 9 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 11 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 14 |
| 2024 | 14 |
| 2025 | 7 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 39 |
| Recruiting | 20 |
| Completed | 19 |
| Not yet recruiting | 10 |
| Active, not recruiting | 4 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 10 |
| Changhai Hospital | 7 |
| Fudan University | 5 |
| Huazhong University of Science and Technology | 5 |
| RenJi Hospital | 5 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 3 |
| Fuda Cancer Hospital, Guangzhou | 3 |
| Ruijin Hospital | 3 |
| Shanghai Proton and Heavy Ion Center | 3 |
| Zhejiang University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 93 |
| Stomach Neoplasms | 7 |
| Cholangiocarcinoma | 6 |
| Breast Neoplasms | 4 |
| Duodenal Neoplasms | 4 |
| Liver Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Neoplasms | 4 |
| Bile Duct Neoplasms | 3 |
| Carcinoma, Hepatocellular | 3 |
Trials
Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.